Periodic Reporting for period 2 - Phoenix (Pharmaceutical Open Innovation Test Bed for Enabling Nano-pharmaceutical Innovative Products)

The establishment of current good manufacturing practice (cGMP) in nano-pharmaceutical production at large scale represents the first prerequisite to transfer successfully the nano-pharmaceuticals from bench to bedside (from lab scale to industrial scale). Nano-pharmaceuticals...